During Phase II, Axxiem consulted with Singular Immune to create the site's structure and content around the key messages and desired audience. Singular Immune explained to Axxiem the science behind their MOA and they're very pleased with the resulting animation that clearly tells their story of a recombinant protein-based in vivo cell-engineering platform offering simple, safe, and cell-free treatment.
